Marking the third time it will be provided at the practice, HerScan, a revolutionary breast cancer detection system, will be offered from 8:30 a.m. to 4:30 p.m. on May 11, 2023, at Anasa Personalized Medicine, in Providence, Rhode Island. The ultrasound screening procedure, most recently provided at Anasa last fall, is painless, doesn’t involve compression or radiation or necessitate a prescription and is also implant-safe.

Studies have shown that ultrasound increases detection rates of breast cancer from approximately 48 percent to 97 percent, particularly in women with dense breasts. Previous users have attested that the HerScan procedure has saved lives and is “the best service anyone with breasts can do for themselves.”